ICD Q61.2ORPHA:730ADPKD

Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, causing fluid-filled cysts to grow in the kidneys over decades and often leading to kidney failure. It affects approximately 25,000 Australians. The first disease-modifying treatment (tolvaptan) is now available, and research into additional therapies is progressing rapidly.

796
Articles
165
Trials (10 AU)
Updated
25 March 2026
Loading...

Common Questions

What is Autosomal Dominant Polycystic Kidney Disease?

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, causing fluid-filled cysts to grow in the kidneys over decades and often leading to kidney failure. It affects approximately 25,000 Australians. The first disease-modifying treatment (tolvaptan) is now available, and research into additional therapies is progressing rapidly.

How many clinical trials are available for Autosomal Dominant Polycystic Kidney Disease?

RareWays currently indexes 165 clinical trials for Autosomal Dominant Polycystic Kidney Disease, of which 38 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Autosomal Dominant Polycystic Kidney Disease come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Autosomal Dominant Polycystic Kidney Disease.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.